VistaGen Therapeutics, Inc. Skyrocketed
Fri, Dec 18, 2020 at 05:30 PM
VistaGen Therapeutics, Inc. (VTGN:NASDAQ) soared at $1.36, a gain of 46.9%. On Thu 17 Dec 20, VTGN:NASDAQ hit a New 2-Week High of $0.93. The stock got featured on our News Catalysts scanner on Fri 18 Dec 20 at 08:49 AM in the 'PUBLIC OFFERING' category. From Thu 03 Dec 20, the stock recorded 50.00% Up Days and 36.36% Green Days
The stock spiked on Tue 11 Aug 20 at $1.06 with a volume of 5M+.
About VistaGen Therapeutics, Inc. (VTGN:NASDAQ)
VistaGen Therapeutics Inc is a clinical-stage biopharmaceutical company that develops and commercializes product candidates for patients with central nervous system diseases. Its product AV-101 is currently being evaluated in a Phase 2 monotherapy study.
Top 10 Gainers:
- LFTR (LFTR:NASDAQ), 100%
- CURO Group Holdings Corp. (CURO:NYSE), 88.74%
- Mereo BioPharma Group plc (MREO:NASDAQ), 62.9%
- FGF (FGF:NASDAQ), 50.96%
- CYREN Ltd. (CYRN:NASDAQ), 50.03%
- VistaGen Therapeutics, Inc. (VTGN:NASDAQ), 46.92%
- FinServ Acquisition Corp. (FSRV:NASDAQ), 36.36%
- Ampio Pharmaceuticals, Inc. (AMPE:NYSEMKT), 35.39%
- FireEye, Inc. (FEYE:NASDAQ), 33.73%
- Organovo Holdings, Inc. (ONVO:NASDAQ), 29.31%